Log in to save to my catalogue

Mutated ITP53/I in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Ca...

Mutated ITP53/I in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A766927304

Mutated ITP53/I in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

About this item

Full title

Mutated ITP53/I in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

Publisher

MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2023-09, Vol.13 (9)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Circulating tumor DNA (ctDNA) has been suggested as a surrogate biomarker for early detection of cancer recurrence. We aimed to explore the utility of ctDNA as a noninvasive prognostic biomarker in newly diagnosed head and neck squamous cell carcinoma (HNSCC) patients. Seventy HNSCC specimens were analysed for the detection of TP53 genetic alterati...

Alternative Titles

Full title

Mutated ITP53/I in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A766927304

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A766927304

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom13091418

How to access this item